Guardant Health
GH
#1549
Rank
HK$103.45 B
Marketcap
HK$796.59
Share price
-1.73%
Change (1 day)
181.53%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total debt

Total debt on the balance sheet as of September 2025 : HK$10.32 Billion

According to Guardant Health 's latest financial reports the company's total debt is HK$10.32 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Guardant Health - Total debt on balance sheet (from 2017 to 2025)

Total debt by year

Year Total debt Change
2024-12-31HK$10.37 B-1.9%
2023-12-31HK$10.57 B-1.17%
2022-12-31HK$10.69 B-0.12%
2021-12-31HK$10.71 B61.71%
2020-12-31HK$6.62 B2005.53%
2019-12-31HK$0.31 B
2018-12-31N/A-100%
2017-12-31HK$5.14 M-96.1%
2016-12-31HK$0.13 B

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Natera
NTRA
HK$1.54 B-85.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
HK$6.16 B-40.25%๐Ÿ‡บ๐Ÿ‡ธ USA